These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29328441)

  • 1. Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner.
    Wang X; Liu Y; Liu W; Zhang Y; Guo F; Zhang L; Cui M; Liu S; Wu R
    Mol Med Rep; 2018 Mar; 17(3):4531-4539. PubMed ID: 29328441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
    Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
    Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
    BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
    Liu S; Xie F; Wang H; Liu Z; Liu X; Sun L; Niu Z
    Oncol Rep; 2015 Mar; 33(3):1372-80. PubMed ID: 25571917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells.
    Wang X; Liu Y; Wu R; Guo F; Zhang L; Cui M; Wu X; Zhang Y; Liu W
    Onco Targets Ther; 2018; 11():943-953. PubMed ID: 29503569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells.
    Han L; Zhao Q; Liang X; Wang X; Zhang Z; Ma Z; Zhao M; Wang A; Liu S
    Oncotarget; 2017 Jul; 8(28):45643-45655. PubMed ID: 28484091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of tumor cell invasion and induction of apoptosis by ubenimex].
    Zheng YB; Gong JH; Li Y; Zhen YS
    Yao Xue Xue Bao; 2012 Dec; 47(12):1593-8. PubMed ID: 23460963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway.
    Wang Y; Pang B; Zhang R; Fu Y; Pang Q
    Drug Des Devel Ther; 2019; 13():3217-3228. PubMed ID: 31571825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death.
    Liu S; Wang X; Lu J; Han L; Zhang Y; Liu Z; Ding S; Liu Z; Bi D; Niu Z
    Oncol Lett; 2016 Nov; 12(5):3403-3410. PubMed ID: 27900012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
    Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
    Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Toshiyama R; Konno M; Eguchi H; Takemoto H; Noda T; Asai A; Koseki J; Haraguchi N; Ueda Y; Matsushita K; Asukai K; Ohashi T; Iwagami Y; Yamada D; Sakai D; Asaoka T; Kudo T; Kawamoto K; Gotoh K; Kobayashi S; Satoh T; Doki Y; Nishiyama N; Mori M; Ishii H
    Oncogene; 2019 Jan; 38(2):244-260. PubMed ID: 30089817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy flux inhibition, G2/M cell cycle arrest and apoptosis induction by ubenimex in glioma cell lines.
    Han L; Zhang Y; Liu S; Zhao Q; Liang X; Ma Z; Gupta PK; Zhao M; Wang A
    Oncotarget; 2017 Dec; 8(64):107730-107743. PubMed ID: 29296201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
    Li C; Zhai W; Wan L; Li J; Huang A; Xing S; Fan K
    J Cell Biochem; 2020 Feb; 121(2):1716-1727. PubMed ID: 31595566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
    Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
    Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
    Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy.
    Jiang Y; Li X; Hou J; Huang Y; Wang X; Jia Y; Wang Q; Xu W; Zhang J; Zhang Y
    Eur J Med Chem; 2018 Jan; 143():334-347. PubMed ID: 29202398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
    Zhao L; Zhang J; Fan Y; Li Y
    Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
    Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
    Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.